Added value of pre-biopsy prostate multiparametric MRI in biopsy-naïve patients: Preliminary results of the MRI-FIRST trial

Rouvière, Olivier; Puech, Philippe; Penna, R. Renard; Claudon, M.; Roy, C.; Lechevallier, F. Mège; Decaussin‐Petrucci, Myriam; Rabilloud, M.; Pethelaz, A.M. Schott; Chambardel, M. Dubreuil; Delongchamps, Nicolas Barry; Boutier, R.; Bratan, Flavie; Brunelle, Serge; Camparo, Philippe; Colin, P.; Corréas, J.M.; Cornud, F.; Descotes, J; Eschwège, P.; Fiard, G.; Fendler, Jean-Philippe; Habchi, Hocine; Khairoune, A.; Lang, Hervé; Lebras, Y.; Malavaud, Bernard; Moldovan, Paul Cezar; Mottet, N.; Mozer, Pierre; Nevoux, P.; Pagnoux, G.; Pasticier, G.; Portalez, D.; Potiron, E.; Timsit, Marc‐Olivier; Villers, Arnauld; Walz, J.; Colombel, M.; Ruffion, A.; Crouzet, Sandrine; Lemaître, L.; Grenier, N.

doi:10.1016/s1569-9056(17)30558-4

European Urology Supplements

2017

DOI: 10.1016/s1569-9056(17)30558-4

|View full text |Cite

Added value of pre-biopsy prostate multiparametric MRI in biopsy-naïve patients: Preliminary results of the MRI-FIRST trial

Olivier Rouvière¹,

Philippe Puech²,

R. Renard Penna³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Added value of pre-biopsy prostate multiparametric MRI in biopsy-naïve patients: Preliminary results of the MRI-FIRST trial

Cited by 2 publications

References 0 publications

RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate

RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate

Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate

Contact Info

Product

Resources

About